Efficacy of Pitolisant 20 mg in Reducing Excessive Daytime Sleepiness and Fatigue in Patients with Obstructive Sleep Apnoea Syndrome: An Individual Patient Data Meta-analysis
ConclusionThe results provide evidence of a significant benefit of pitolisant in improving EDS and fatigue, irrespective of baseline conditions.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Drugs & Pharmacology | Neurology | Obstructive Sleep Apnea | Sleep Disorders | Sleep Medicine | Study